🇺🇸 FDA
Pipeline program

phenytoin

199/12249

Phase 3 small_molecule completed

Quick answer

phenytoin for Post-Traumatic Seizure Disorder is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Post-Traumatic Seizure Disorder
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials